Royal Bank of Canada Reaffirms “Outperform” Rating for IQVIA (NYSE:IQV)
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank of Canada in a research report issued on Monday,Benzinga reports. They currently have a $270.00 target price on the medical research company’s stock. Royal Bank of Canada’s price target would indicate a potential upside of 34.37% from the company’s current […]
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank of Canada in a research report issued on Monday,Benzinga reports. They currently have a $270.00 target price on the medical research company’s stock. Royal Bank of Canada’s price target would indicate a potential upside of 34.37% from the company’s current […]
